Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.185 CAD | -5.13% |
|
0.00% | +5.71% |
Jun. 20 | Theralase Technologies Inc. Announces Rutherrin Repurposes Non-Cancer Drugs for Cancer Therapy | CI |
Jun. 12 | Theralase Technologies Inc. Announces Rutherrin Increases Efficacy of Chemotherapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.71% | 34.07M | |
-3.38% | 808M | |
-33.08% | 210M | |
0.00% | 108M | |
-34.78% | 79.84M | |
-2.90% | 52.56M |
- Stock Market
- Equities
- TLT Stock
- News Theralase Technologies Inc.
- Theralase Technologies Donates Cool Laser Therapy Technology to Aid in R&D of Treatment for Parkinson's Disease